Fellowship

The Australian Academy of Health and Medical Sciences elects the best and brightest minds in the field of medical and health sciences as Fellows.

Fellows are elected in recognition of their outstanding achievements and exceptional contributions to the sector. The Fellowship are acknowledged for their clinical, non-clinical, leadership, industry and research contributions.

About Fellowship with AAHMS

Find Fellows of the AAHMS

To find Fellows of our Academy either use the search form below or download the full list of current Fellows here.

Search
Generic filters
Search
Generic filters

Name

Position

Level

Elected

State

Professor of Ophthalmology, Centre for Ophthalmology and Visual Science
Lions Eye Institute, The University of Western Australia
Fellow
2015
WA

Professor David Mackey is a world leader in the translation of genetic eye disease research into treatment. Gene discovery allows accurate diagnosis, predictive testing and genetically guided treatment. David has also evaluated the ethics and cost effectiveness of gene based testing. He is President of the International Society of Genetic Eye Disease and Retinoblastoma; a member of the NHMRC Human Genetics Advisory Committee; teacher and examiner for the Royal Australian and New Zealand College of Ophthalmologists; wrote the genetics chapters for the American Academy of Ophthalmology basic text books. He has trained ophthalmology registrars, fellows and supervises medical, Masters and PhD students.

Senior Principal Research Fellow
Neuroscience Research Australia
Fellow
2015
NSW

Professor Lord has pursued work in the areas of applied neurology, instability, falls and fractures in older people and clinical groups. He has made major contributions in these fields with studies spanning basic physiology, risk factor identification, development and evaluation of randomised controlled trials and guideline and policy development. His evidence-based risk assessment tools are now used widely in clinical settings for identify high risk populations and guiding optimal intervention strategies. He has published over 350 papers (H index 65) and is one of the top 1% most cited researchers worldwide for the field of social science.

AO FAA FAHMS
Director, Centre for Cancer Biology
SA Pathology and University of South Australia
Fellow
2015
SA

Professor Angel Lopez is an outstanding Australian scientist with an international reputation in human cytokines or growth factors, particularly on studies of cytokine families with a shared receptor subunit. He has made several breakthroughs that have illuminated how these cytokines exert their biological activities and revealed new paradigms that apply to the cytokine superfamily at large. His unique insights into cytokine function, receptor recognition and signalling, together with his leadership in translation into public health benefits, have paved the way for the development of novel drugs for the treatment of usually fatal myeloid leukaemias and debilitating chronic inflammatory diseases.

Joint Head, Stem Cells and Cancer Division
The Walter and Eliza Hall Institute of Medical Research
Fellow
2015
VIC

Professor Geoffrey Lindeman and his team identified breast stem and progenitor cells that generate all ductal tissue in the breast. His group’s discoveries helped define breast development from long-lived stem cells to progenitor and mature epithelial cells, providing a new framework for studying the molecular and cellular events that give rise to breast cancer. His group was the first to identify the culprit progenitor cell responsible for breast cancer in BRCA1 mutation carriers. In parallel, Lindeman has established a leading translational research program, made important contributions to tissue banking for cancer research, and helped advance research and clinical services in hereditary cancer.

Senior Vice President for Academic Affairs & Executive Dean
SUNY Upstate Medical University
Fellow
2015
International

Professor Licinio is an internationally recognised translational research leader in major depression, its biology and metabolic outcomes. His h-index is 60, with 18000 citations and publications in leading journals, such as Nature, Science, Cell, PNAS, and Lancet. He is an RANZCP Fellow with AHPRA registration as specialist in psychiatry. He is a member of the Scientific Program Committee, American Psychiatric Association, the Membership Committee, American College of Neuropsychopharmacology, and he is founding (and current) Chief Editor of three Nature Publishing Group journals: Translational Psychiatry (IF=4.36), The Pharmacogenomics Journal (IF=5.5), and Molecular Psychiatry (IF=15.147), ranked number 1 in its field worldwide.

Director
The Doherty Institute
Fellow
2014
VIC

Professor Sharon Lewin is the inaugural director of the Doherty Institute for Infection and Immunity at the University of Melbourne; consultant physician, Alfred Hospital, Melbourne, Australia; and an Australian National Health and Medical Research Council (NHMRC) Practitioner Fellow. She is an infectious diseases physician and basic scientist and an internationally recognised expert on HIV disease and pathogenesis. She was previously Head, Department of Infectious Diseases, The Alfred Hospital and Monash University (2003 – 2014) and Co-head, Centre for Biomedical Research, Burnet Institute (2010-2014), Melbourne, Australia.

She completed her medical training at Monash University, followed by a PhD in virology at the Burnet Institute in Melbourne and a post-doctoral fellowship at the Aaron Diamond AIDS Research Center, The Rockefeller University in New York. Her laboratory focuses on strategies to cure HIV infection, immune reconstitution following antiviral therapy and the pathogenesis of HIV-hepatitis B co-infection.

Professor Lewin has received continuous research funding from the NHMRC since 1993 and funding from the National Institutes for Health, the Wellcome Trust and the American Foundation for AIDS Research. She was the local co-chair of the XXth International AIDS Conference (AIDS2014), which was held in Melbourne July 2014, and was the largest health conference ever held in Australia. She was previously President of the Australian Society for HIV Medicine (2005-2007), is on the leadership team of the International AIDS Society’s Strategy Towards an HIV Cure and a member of the Australian Government Ministerial Advisory Committee on Blood Borne Viruses and Sexually Transmitted Infections.

Director
Harry Perkins Institute of Medical Research
Fellow
2015
WA

Professor Leedman is an internationally recognised physician scientist who combines academic translational cancer research and teaching, with running the Harry Perkins Institute of Medical Research and clinical endocrinology. His research has led to several key discoveries on hormone action in cancer as well as patents and company development (MiReven). He has had many senior leadership roles in H&MR, including senior NHMRC activities, Advisory Committees and Chairman of companies, such as Linear Clinical Trials Ltd. He has been recognised with awards from the Australian & UK Endocrine Societies and the WA Government for Innovator of the Year in 2013 for MiReven.

Emeritus Professor
Monash University
Fellow
2015
VIC

Professor Richard Larkins has combined clinical work in endocrinology and general medicine with research into the causes and complications of diabetes, vitamin D metabolism and other aspects of diabetes and endocrinology. As a clinical academic he was the James Stewart Professor of Medicine for 14 years and Dean of the Faculty of MDHS at the University of Melbourne for 5 years. He ceased active medical practice when he became Vice-Chancellor and President of Monash University in 2003. Other leadership positions held have included Chair of the National Health and Medical Research Council, President of the Royal Australasian College of Physicians, President of the Endocrine Society of Australia, Chair of the Accreditation Committee of the Australian Medical Council and Chair of Universities Australia. He remains active in medical and research policy as Chair of the Victorian Comprehensive Cancer Centre partnership, Chair of the Council of EMBL Aust, President of the National Stroke Foundation and Chair of the Australian Synchrotron Holding Company.

Professor
The University of Western Australia
Fellow
2015
WA

Professor Nigel Laing is a world-renowned scientist whose work has turned Australia into an international reference centre for neuromuscular diseases. He has identified more than twenty human disease genes and has the rare honour of having a disease named after him. He established the premier diagnostic laboratory for neurogenetic disorders in Australasia, receiving patient samples from around the world.

Nigel actively engages with patient support groups, raising public understanding of medical science.

As a leader, he has been elected five times to the World Muscle Society Board, is a Member of Senate of UWA and is an awarded mentor.

AM FAA FAHMS
Co-Director, Centre for Cancer Biology
SA Pathology and The University of South Australia
Fellow
2015
SA

Professor Sharad Kumar’s ground-breaking work in biomedical sciences has been recognised through prestigious fellowships, national and international awards, and election to the Fellowship of the Australian Academy of Science. He has made seminal discoveries that have significantly contributed to the understanding of human diseases such as cancer, inflammation and hypertension. His publications have received extensive citations. With Angel Lopez he established the Centre for Cancer Biology, a leading research centre in South Australia. He has built collaborative teams, bringing major infrastructure funding and contributed to research community extensively through leadership, mentoring and peer review.

Our Fellows sit at the heart of everything we do. They represent Australia’s leading minds in health and medical sciences, having been recognised for their clinical, non-clinical, leadership, industry and research contributions.

To be considered for election to the Academy’s Fellowship, a candidate must show exceptional professional achievement in a field related to health and/or medicine.

Fellows contribute to the projects and activities of the Academy and must be willing to be active participants. 

Successful Fellowship candidates will have shown:

  • Outstanding leadership in their field.
  • Significant and ongoing involvement with issues of health care, prevention of disease, education, research, and health services policy and delivery.

Candidates for Fellowship should meet the following criteria:

  • National and International recognition for excellence in health and medical science
  • Significant, sustained and ongoing contributions to advance health and medical science in Australia (relative to opportunity)
  • Contribution to the profession through leadership and mentorship
  • Raised public understanding and promoting health and medical science in the broader community
      •  

Download criteria for Fellowship

Each year, current Fellows of the Academy are invited to nominate up to four new candidates who meet the criteria and fulfil the required expectations.

Nominations by a Fellow of two new candidates must ensure that at least one nomination is a woman. Nominations by a Fellow of four new candidates must ensure that at least two nominations are women.

How to make a nomination

Fellows wishing to nominate a candidate for Fellowship should contact the Secretariat for application forms and further instructions on how to submit the completed nomination documentation. 

Fellows wishing to nominate a candidate for a Corresponding Fellowship should contact the Secretariat for more information.

Secretariat contact details
Email: [email protected]

Phone: 07 3102 7220

Nomination guidelines for ordinary Fellowship

October 2021
Newly elected Fellows of 2021 are inducted at the AGM/Scientific Meeting.

October 2021-November 2021
Nominations are invited from existing Fellows until the closing date of 30 November.

December 2021
Nominations allocated to Selection Committees.

January – April 2022
Referees’ reports sought.

Early May 2022
Selection Committees meet to consider nominations and provide final recommendations to the Council.

Early-to-Mid-July 2022
Council meets to finalise recommendations.

Late July 2022
Full Fellowship invited to comment on recommended new fellows.

Early August 2022
Newly elected Fellows are informed of their successful appointment.

October 2022
Newly elected Fellows of 2022 inducted at the AGM/Scientific Meeting.

Find out more

Whether you’re looking to nominate a colleague for an award, make a donation to the Academy or simply find out more about the work we do, research we advance and health policy advice we provide, sign up to our mailing list today.

Keep up to date with the latest news

By providing your email address, you consent to it being added to our mailing list.